Close Menu

NEW YORK ─ SummerBio on Wednesday announced it has raised $7.3 million in an equity financing round and is conducting testing for the University of California Los Angeles (UCLA) and the Los Angeles Unified School District that leverages its RT-PCR SARS-CoV-2 test.

Investors in the equity financing round included Intel Capital, Capricorn Investment Group, 8VC, Toyota AI Ventures, Joby Trust, Dayton Family Enterprises, and Sciarra Management Trust.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The UK has given emergency authorization for Pfizer and BioNTech's SARS-CoV-2 vaccine, the Associated Press reports.

A US advisory committee says healthcare workers and nursing home residents should be prioritized to receive a SARS-CoV-2 vaccine, according to the Financial Times.

The Wall Street Journal reports North Korean hackers have targeted half a dozen companies developing SARS-CoV-2 vaccines.

In Cell this week: long-term SARS-CoV-2 shedding, examination of the effects of a coronavirus spike protein mutation, and more.